HOME > TOP STORIES
TOP STORIES
-
BUSINESS UCB Japan Gathers Pace in Rare Disease Space with 2 New Launches for gMG
November 28, 2023
-
REGULATORY Meiji’s mRNA Vaccine, Pfizer’s RSV Vaccine Now in Line for Approval
November 28, 2023
-
REGULATORY Japan Deeping Debate on LLP Copay Review; Focus Is on Exclusion Criteria, Payment Levels, G1/G2 Rule Change
November 27, 2023
-
REGULATORY Chuikyo Reps Split on Nixing PMP Company Criteria; Many Back Review of Reduction Caps under Re-Pricing
November 24, 2023
-
BUSINESS Phesgo, Epkinly, Leqvio Hit Japan Market, Wegovy Launch Set for Feb. 22
November 24, 2023
-
BUSINESS BMS Japan Has Busy Years Ahead with String of Launches towards Doubling of Sales
November 22, 2023
-
REGULATORY MOF Panel Renews Call for Full Execution of Annual Price Cuts, Urges LLP Copay Review: Budget Proposal
November 21, 2023
-
REGULATORY Pharma Fiercely Opposes Proposed CEA Cut into Drug Base Price: Chuikyo Hearing
November 20, 2023
-
REGULATORY Japan Agrees to Buy 1.4 Million Doses of Daiichi Sankyo’s COVID Vaccine
November 17, 2023
-
BUSINESS Japanese Pricing Rules Don’t Fully Capture Value of New Modalities, “No” to CEA Expansion: Janssen Exec
November 17, 2023
-
REGULATORY Wegovy Lands Reimbursement Listing in Japan 8 Months after Approval
November 16, 2023
-
ORGANIZATION PhRMA Chief Presses Japan to Cut LLP Spending, Shift Funds towards Innovation
November 15, 2023
-
REGULATORY Japan Health Minister Seeks Industry Input for Detailed Discussions on Innovation Ecosystem
November 14, 2023
-
BUSINESS Ajinomoto to Acquire US Gene Therapy CDMO for US$554 Million
November 14, 2023
-
REGULATORY MHLW Proposes New Premium with Easier-than-Sakigake Requirements to Fight Lag, Loss
November 13, 2023
-
REGULATORY Japan Panel Supports Certain Out-of-Pocket Payment for LLP-Generic Price Gap
November 10, 2023
-
ORGANIZATION PhRMA Chair Urges Japan to Maintain On-Patent Drug Prices, Improve Initial Pricing
November 10, 2023
-
BUSINESS Middle East Unrest Threatens Supply of Kaken’s Burn Eschar Remover
November 9, 2023
-
REGULATORY Health Minister Asks 24 Makers to Raise Production of Antitussives, Expectorants; Firms Want Regulatory, Pricing Steps
November 8, 2023
-
REGULATORY Govt to Support Shift to 24-Hour Production for Cough Drugs: Minister
November 8, 2023
ページ
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
